Australia

Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in Italy

MELBOURNE, Australia and SAN FRANCISCO, June 23, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the Italian Medicin...

2022-06-23 23:00 2370

FIM World Supercross Championship Unveils New Logo in Global Brand Identity Reveal

Inspired by the Past & Driven Toward the Future, Official Logo and Colors Will Be Synonymous with Supercross' Premier Global Championship for Years to Come QUEENSLAND, Australia, June 23, 2022 /PRNewswire/ -- SX Global, the Australian sports and entertainment company spearheading the FIM World S...

2022-06-23 22:30 2325

Process Intelligence and Automation Success Honoured with 2022 Nintex Solution Innovation Awards

26 organisations recognised in Nintex's annual customer awards program, which celebrates public and private sector organisations in every industry and geography for their digital transformation success with the Nintex Process Platform MELBOURNE, Australia, June 23, 2022 /PRNewswire/ -- Nintex, t...

2022-06-23 07:23 1651

NEW CAMPAIGN CELEBRATES PREMIUM AUSTRALIAN LEATHER

WARWICK, Australia, June 22, 2022 /PRNewswire/ -- The Kangaroo Industry Association ofAustralia (KIAA) is calling for designers of fashion, footwear, and apparel, together with industry which values high performance leather such as premium soccer boots and heavy-duty sports, to embrace kangaroo l...

2022-06-22 18:00 1535

Trajan to acquire leading chromatography consumables and tools business building critical mass in the gas chromatography portfolio

Highlights * Trajan to acquire Chromatography Research Supplies, Inc. (CRS), a leading global manufacturer of high-quality analytical consumables * Provides Trajan with enhanced and extended production capabilities to service its growing gas chromatography business. Strengthens Trajan's produ...

2022-06-19 22:15 2441

ENGINE in the US, Europe, and Australia Rebrands to Big Village, Pioneering the Future of Global Advertising, Technology, Insights and Data

Under its new corporate entity, Big Village unites adtech, insights and media, under one roof to solve the industry's biggest pain points and advance advertising forward for a new era NEW YORK, June 18, 2022 /PRNewswire/ -- ENGINE, a global advertising, technology, and data company, today announ...

2022-06-18 07:00 5466

US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER

SYDNEY, June 17, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to Kazia's paxalisib for the treatmen...

2022-06-17 20:00 3838

Bechtel launches second round of STEM Returners program

Career-break engineers helping to shape team performance BRISBANE, Australia, June 16, 2022 /PRNewswire/ -- Bechtel announced today launch of second intake of STEM returners at theirAustralia offices in Brisbane andPerth following the success of the pilot program in 2021. The new intake will ope...

2022-06-17 10:05 2389

LiveHire and Enboarder Announce Partnership to Deliver Next-Generation Onboarding Experience

The integrated solution combines the power of LiveHire's Total Talent and Direct Sourcing Platform with Enboarder's People Activation Platform to deliver more personalized experiences for onboarding new talent MIAMI, June 15, 2022 /PRNewswire/ -- LiveHire Ltd. (ASX: LVH), a global software-as-a-...

2022-06-16 01:00 2175

LexisNexis Risk Solutions Study Estimates Australian Financial Services Firms Will Spend More Than U.S. $2.54 Billion on Financial Crime Compliance in 2022

Retail and Ecommerce Merchants Projected to Have Highest Money Laundering Risks SYDNEY, June 15, 2022 /PRNewswire/ -- LexisNexis® Risk Solutions today released its firstAustralia edition of the LexisNexis True Cost of Compliance™ Study. The study revealed that Australian financial services compa...

2022-06-15 08:00 2277

Telix and Invicro Advance AI Partnership

MELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has advanced a partnership with Invicro LLC (Invicro), a global, industry-leading imaging CRO, and part of REALM IDx, Inc., to develop an artificial...

2022-06-14 19:00 2067

TradeWindow Standardises on Nintex Promapp to Support Global Growth

Software development company uses Nintex Promapp to discover, map, manage and govern its organisational business processes MELBOURNE, Australia, June 14, 2022 /PRNewswire/ -- Nintex, the global standard for process intelligence and automation, today announced that software company TradeWindow ha...

2022-06-14 07:17 2385

Jubilant Radiopharma Joins Illuccix® Pharmacy Partner Network

MELBOURNE, Australia and INDIANAPOLIS, June 13, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce that its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga 68 gozetotide), is now available at selected pharmacies in ...

2022-06-13 19:11 2123

Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over

* In Australia, Nuvaxovid™ is the first protein-based COVID-19 vaccine registered for use as a booster regardless of previous vaccine history GAITHERSBURG, Md., June 13, 2022 /PRNewswire/ -- Novavax, Inc. (NASDAQ: NVAX), a biotechnology company dedicated to developing and commercializing next-...

2022-06-13 19:00 2259

POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING

SYDNEY, June 13, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of new data regarding the activity of paxalisib in two forms of childhood brain cancer with poor prognosis and limited t...

2022-06-13 19:00 4218

Telix and RefleXion Expand Partnership for Prostate Cancer Treatment

MELBOURNE, Australia and INDIANAPOLIS, June 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) today announced the signing of a co-development and commercialisation agreement, to expand the use ...

2022-06-10 19:00 2825

RAD adds brain tumor technology to portfolio

* Sublicensing of promising imaging & therapeutic radiopharmaceutical from leading US university,Case Western Reserve University (CWRU), Ohio * PTPµ (PTPmu), the target, is a unique biomarker present only in tumor cells but not healthy cells * The radionuclide carrying PTPµ-targeting agent h...

2022-06-10 10:21 2107

World leading organisations support IAF's global certificate database

SYDNEY, June 9, 2022 /PRNewswire/ -- The International Accreditation Forum  (IAF) established a global certificate database to help industry and regulators verify valid accredited certifications across the globe. https://www.iafcertsearch.org/ ...

2022-06-09 23:00 2807

Techtronic Industries Australia selects One Network Enterprises to Enhance Supplier Collaboration for Improved Demand and Supply Planning

One Network's Leading Control Tower will be deployed on its Digital Supply Chain Network™ to deliver multi-tier visibility, collaboration, and execution capabilities, to accelerate TTI's digital transformation. DALLAS, June 7, 2022 /PRNewswire/ -- One Network Enterprises(ONE), the leading global...

2022-06-07 21:00 2385

Telix to Present at Jefferies Healthcare Conference

MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR) advises t...

2022-06-07 19:00 1418
1 ... 15161718192021 ... 55